Results 111 to 120 of about 32,907 (227)

Hyperkalemia and hyporeninemic hypoaldosteronism

Kidney International, 1980
Presentation of the Forum is made possible by grants from Hoechst-Roussel Pharmaceuticals Inc., Smith Kline & French Laboratories, G.D. Searle & Co., Warner-Lambert Pharmaceutical Division, Burroughs Wellcome Company, Geigy Pharmaceuticals Inc., Ciba Pharmaceuticals Inc., and Boehringer Ingel-heim Ltd.
openaire   +2 more sources

Management of hyperkalemia: Expert consensus from Kuwait – a Modified Delphi Approach

Ali AlSahow,1 Bassam Bulbanat,2 Bassam Alhelal,3 Khaldoun Alhumoud,4 Ahmad Alkharaza,5 Torki Alotaibi,6 Heba Alrajab,7 Anas Alyousef,8 Fatimah Hadi9 1Nephrology division, Jahra Hospital, Al Jahra, Kuwait; 2Cardiac Center, Amiri Hospital, Kuwait City ...
AlSahow A, Alyousef A, Alhelal B, Bulbanat B, Alkharaza A, Alotaibi T, Hadi F, Alrajab H, Alhumoud K   +8 more
core  

Treatment of Severe Hyperkalemia: Confronting 4 Fallacies

, 2018
Severe hyperkalemia is a medical emergency that can cause lethal arrhythmias. Successful management requires monitoring of the electrocardiogram and serum potassium concentrations, the prompt institution of therapies that work both synergistically and ...
J. Gary Abuelo
core   +1 more source

Primidone Usage as a Rare Cause of Drug-Induced Hyperkalemia

Turkish Journal of Nephrology, 2019
Hyperkalemia is a life-threatening electrolyte disorder. Elderly patients are more prone to developing hyperkalemia due to age-related decline in glomerular fi ltration rate.
Mehmet BÜYÜKBAKKAL, Barış ESER, Özlem YAYAR, Zafer ERCAN, Aysun KUTLUGÜN, Hadim AKOĞLU, Bülent ERDOĞAN, Özgür MERHAMETSİZ, Mehmet Deniz AYLI   +8 more
doaj  

Extremely rare cause of hyperkalemia: ileostomy‒induced hyperkalemia in extremely low birth weight infants

The Turkish Journal of Pediatrics
Background. Hyperkalemia is one of the most serious electrolyte disturbances, and it can cause lethal cardiac arrhythmia. Although hyperkalemia associated with ileostomies has been reported in adults, to the best of our knowledge, it has not previously ...
Mehmet Mutlu, Yakup Aslan, Şebnem Kader, Emine Ayça Cimbek, Gül Şalcı   +4 more
doaj   +1 more source

Hyperkalemia Is an Underestimated Risk Factor in COPD

International Journal of COPD
Jukka Mäenpää,1 Isobel Anderson,2 Caroline A Owen,3 Ulrika Emerath,1 Rod Hughes,4 Stefan R Sultana,5 Marita Olsson6 1Chief Medical Office, Research & Development, Patient Safety Biopharma, AstraZeneca, Gothenburg, Sweden; 2Patient Safety Operations ...
Mäenpää J, Anderson I, Owen CA, Emerath U, Hughes R, Sultana SR, Olsson M   +6 more
doaj  

Hyperkalemia in young children : blood pressure checked?

, 2016
: Hyperkalemia in young children is a rare phenomenon and in many cases caused by hemolysis in the specimen due to difficulties in obtaining a sample. However, hyperkalemia can also be a sign of a rare Mendelian syndrome known as familial hyperkalemic ...
van Hoeck, Koen, Hollander, Richard, Mortier, Geert   +2 more
core  

Frequency, Management, and Outcomes of Outpatient Hyperkalemia: A Population-Based Cohort Study

Canadian Journal of Kidney Health and Disease
Background: Hyperkalemia is a potentially life-threatening condition, with guidelines recommending urgent treatment when the serum potassium level is greater than 6.0 mmol/L.
Michael Chiu, Nivethika Jeyakumar, Graham Smith, Danielle M. Nash, Mohamed Abou El Hassan, Dana Bailey, Peter Catomaris, Kika Veljkovic, Louise Moist, Amit X. Garg, Arsh K. Jain   +10 more
doaj   +1 more source

Hyperkalemia-induced ECG abnormalities in patients with reduced renal function.

, 2004
Hyperkalemia is a potentially lethal condition to be aware of in the presence of ECG abnormalities especially in patients with reduced renal function. However, ECG abnormalities are not always dependent on the degree of hyperkalemia but may be aggravated
Bellotti N., Plati A. R., ESPOSITO, CIRO, FASOLI, GIANLUCA, DAL CANTON, ANTONIO, Foschi A.   +5 more
core  

Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial

, 2016
Background Finerenone reduced risk of cardiorenal outcomes in patients with CKD and type 2 diabetes in the FIDELIO-DKD trial. We report incidences and risk factors for hyperkalemia with finerenone and placebo in FIDELIO-DKD.
Joseph, A., Anker, S.D., Rossing, P., Kolkhof, P., Ruilope, L.M., Wilson, D.J., Agarwal, R., Lawatscheck, R., Filippatos, G., Pitt, B., Bakris, G.L., Scott, C.   +11 more
core